Editorial Policies

Focus and Scope

The Journal of Pediatric and Neonatal Individualized Medicine (JPNIM) is a peer-reviewed interdisciplinary journal which provides a forum on new perspectives in pediatric and neonatal medicine. The aim is to discuss and to bring readers up to date on the latest in research and clinical pediatrics and neonatology. Special emphasis is on developmental origin of health and disease or perinatal programming and on the so-called ‘-omic’ sciences. Systems medicine blazes a revolutionary trail from reductionist to holistic medicine, from descriptive medicine to predictive medicine, from an epidemiological perspective to a personalized approach. The journal will be relevance to clinicians and researchers concerned with personalized care for the newborn and child. Also medical humanities will be considered in a tailored way.

Article submission (original research, review papers, invited editorials and clinical cases) will be considered in the following fields: fetal medicine, perinatology, neonatology, pediatrics, developmental programming, psychology and medical humanities.

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Each unsolicited manuscript is sent to 2/3 reviewers, who evaluate it accordingly with a “single-blind peer review” procedure. For particular research papers, a review can be requested to experts in: bioinformatics, biostatistics, biophysics.

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

In particular, all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute/print a copy for personal and non-commercial use, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is inspired by the BOAI (Budapest Open Access Initiative) definition of open access.

 

Academic re-use

Please note that authors have the opportunity to reuse figures, tables and selected text up to 250 words from their articles as finally published, providing that full and accurate credit shall be given to publication in JPNIM and that modifications are noted (otherwise no changes may be made). Translations are subject to the same rules. For all other academic re-use purposes, please send a request for permission to re-use material to journal@jpnim.com; please state “Academic re-use” in the subject line of your email.

 

Commercial re-use

Whole article re-use or parts of them (in print or electronic copies) can be useful promotional tools at industry-specific exhibitions, workshops, conferences and meetings; they can also be used for commercial and marketing purposes by corporate sales representatives. Commercial re-use includes all uses of JPNIM articles for commercial, promotional, marketing or monetary purposes. Such re-use requires further explicit permission and will be subject to a fee. Commercial re-use includes: all the proactive supplies of multiple print or electronic copies of articles or parts of them taken from JPNIM to third parties on a systematic basis; re-use by a non-author/third party/other publisher of articles or parts of them in another print or electronic publication; re-use by authors of their articles or parts of them, as not otherwise specified in the “Academic re-use” section. Those wishing to re-use parts or all of an article or articles (in print or electronic copies) for commercial purposes are required to pay our commercial rates. Income received helps us to keep our journal freely accessible to readers and not to charge authors any fee for article processing. To request permission and obtain a quotation please contact journal@jpnim.com; please state “Commercial re-use” in the subject line of your email.

 

Indexing

 

Archiving

Long-term preservation is ensured by Portico (a digital preservation and electronic archiving service which is part of ITHAKA, a not-for-profit organization helping the academic community use digital technologies to preserve the scholarly record and to advance research and teaching in sustainable ways). Here you can read the Portico Press Release in which Portico announces the collaboration with us for the preservation of JPNIM.

 

Publishing in JPNIM is free of charge

You can publish in JPNIM free of charge: no payments are required from the Authors. JPNIM doesn’t have article submission charges nor article processing charges (APCs).

 

The steps toward publishing in JPNIM

The steps toward publishing in JPNIM are the following:

  • you can upload your manuscript files online (please note that, to submit articles to JPNIM's website, authors must first be registered as both readers and authors; if you experience problems in submitting a manuscript after registering with the site, please read the step-by-step guide in this pdf) or email them to the Editor-in-Chief Vassilios Fanos (vafanos@jpnim.com);
  • the Editor-in-Chief will make a first evaluation of the article;
  • if it is considered interesting, the article will be sent to 2/3 reviewers, who will evaluate it accordingly with a “single-blind peer review” procedure;
  • the article will be returned to you with the reviewers’ notes and possibly with changes to be made;
  • once you have made the corrections, the article will be forwarded to the reviewers, who will again write their opinions, requiring further corrections or giving their consent to publication;
  • once the peer review process has been completed, a layout version as a PDF file will be prepared, and the proofs will be sent to you so you can check them for the last time and answer queries that may have arisen during the layout process;
  • when you send back the proofs, you will also have to send a signed copyright agreement, where you agree to transfer the copyright to the journal’s publisher;
  • the PDF file will be published online.
Average lenght of time from author submission of manuscript to final published version of article: 3 months.

 

Publication Ethics and Publication Malpractice Statement

Our ethic statements are inspired by COPE’s Best Practice Guidelines for Journal Editors.

In particular:

 

Authorship and Contributorship

Upon publication, the corresponding author must declare that:

  • he/she is the corresponding author for this manuscript. He/she acknowledges that the corresponding author has primary responsibility for correspondence with the journal, and he/she is signing this agreement on behalf of the whole group of authors;
  • the submission has not been previously published, nor is it before another journal for consideration;
  • the manuscript is an original work and I guarantee its originality. He/she guarantees that no parts have been copied by other papers, books, websites, etc.;
  • he/she acknowledges that authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. He/she declares that each and every person listed as author meets conditions 1, 2 and 3. Moreover, he/she acknowledges that acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship;
  • all persons who qualify for authorship are listed as authors;
  • he/she acknowledges that all contributors who do not meet the criteria for authorship should be listed in an Acknowledgments section. In particular, he/she acknowledges that he should declare whether assistance was received for study design, data collection, data analysis, or manuscript preparation. He/she acknowledges that, If such assistance was available, the identity of the individuals who provided this assistance and the entity that supported it in the published article should be disclosed. He/she acknowledges that financial and material support should also be acknowledged.

Moreover, he/she declares that:

  • no assistance was given by people other than authors;
  • OR assistance was given by people other than authors and all contributors are listed in an Acknowledgments section; he/she also certifies that these persons have given him written permission to be acknowledged.

 

 

Conflict of Interest Statement and Funding Acknowledgement

In every article a declaration of interest is published.

Upon publication, the corresponding author must declare that:

  • he/she acknowledges that a conflict of interest exists when an author (or the author’s institution) has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from being negligible to having great potential for influencing judgment. Not all relationships represent true conflicts of interest. The potential for conflict of interest may exist regardless of whether a person believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and science itself. However, conflicts may occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

The corresponding author must also certify that:

  • all funding, other financial support, and material support for this work are clearly identified in the manuscript.

Moreover, the corresponding author must declare that:

  • no conflicts of interest exist;
  • OR conflicts of interest exist and are clearly indicated at the end of the article.

This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated April 2010" made by the International Committee of Medical Journal Editors.

 

 

Human Rights: Protection of Research Participants and Informed Consent

Considering human experimentation, the authors should write whether the procedures followed were in accordance with the ethical standards of the institutional committee on human experimentation.

If no formal ethics committee is available, the authors should indicate whether the procedures were compliant with the Helsinki Declaration as revised in 2008.

Patients have a right to privacy that should not be violated without informed consent. Identifying information (e.g., names, initials, or hospital numbers) should not be published in written descriptions, photographs, or pedigrees unless the information is needed for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.

When informed consent has been obtained, the authors should indicate it when submitting the article.

This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated December 2013" made by the International Committee of Medical Journal Editors.

 

 

Animal Rights

Considering experiments on animals, authors should indicate whether institutional and/or national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare.

This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated December 2013" made by the International Committee of Medical Journal Editors.

 

 

Self-archiving

Authors can archive the 

published paper:


  • publisher's version (the PDF published on the official journal's website) must be used;
  • authors can archive it immediately (without any period of embargo);
  • authors can archive it on their personal websites, institutional website and institutional repositories;
  • authors are kindly encouraged to provide a link to the journal's website.
Self-archive of preprint and postprint is not permitted instead.
JPNIM's self-archiving policy is indexed in SHERPA/RoMEO.

 

Screening for plagiarism

The journal staff has a policy of screening for plagiarism. All articles in this publication are original: the content (either in full or in part) in each article has not been knowingly republished without specific citation to the original release. Plagiarism checker is applied randomly to the majority of the papers submitted.

 

Copyright and publishing rights

Regarding copyright, before publication, Authors declare that, in consideration of the action of JPNIM in reviewing and editing their submission, they transfer, assign, or otherwise convey all copyright ownership, including any and all rights incidental thereto, exclusively to the JPNIM Publisher (Hygeia Press di Corridori Marinella).

Authors have the opportunity to reuse figures, tables and selected text up to 250 words from their article as finally published, providing that full and accurate credit shall be given to publication in JPNIM and that modifications are noted (otherwise no changes may be made).

 

Disclaimer

Disclaimer. Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in the journal and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of this publication.

Drug dosage. The authors, editors and publisher have exerted every effort to be certain that drug selection and dosage set forth in this issue are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or infrequently employed drug.

All rights reserved. All materials are protected by Italian law and by international conventions. No part of this work may be translated into other languages, reproduced or utilized in any form or by any means without the prior written permission of the publisher.

 

Official Journal of the UNEPS and of the Portuguese Neonatal Society

Official Journal UENPS (Union of European Neonatal & Perinatal Societies). Read the articles about JPNIM and UENPS here and here.

UENPS

Official Journal of the Portuguese Neonatal Society (affiliated to the Portuguese Paediatric Society)

Portuguese Neonatal Society



 

N.B. All JPNIM articles are accessible in Open Access. You can access the page containing the full PDF article just by clicking on the “Full Text: PDF” link at the bottom of the abstract page. On the full article page, if the article doesn’t load properly in the PDF view window, please wait a few seconds or click on the “Download this PDF file” link.

Technical advice. If you are using Firefox and you are experiencing problems, please set the browser preferences as follows: Firefox > Preferences > Advanced > General > Accessibility > deselect "Warn me when web sites try to redirect or reload the page".

Privacy Policy. English text: Privacy Policy; Italian text: Privacy Policy.

Cookie Policy. English text: Cookie Policy; Italian text: Cookie Policy.